Fig. 5: Immune cell subsets by pCR status. | British Journal of Cancer

Fig. 5: Immune cell subsets by pCR status.

From: Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy

Fig. 5

Proportion of CD45+ cells which stained positive for a CD3, b CD4, c CD8, d CD56, e CD19, f CD14, and g PD-1 in paired pre- and post-treatment samples based on pCR vs No pCR. A paired Student’s t test was used to determine statistical significance. All p values were corrected for multiple testing, *p < 0.05, **p < 0.01.

Back to article page